40 Dalton Street, Boston,

Boston,

Massachusetts,

US,

ZIP: 02115

Phone: (+1) 617 455 4188

Initially sparked by COVID-19, renewed interest in lipid-based systems for delivery has now evolved. With an escalating clinical demand and the chance to commercialize lipid-based nanoparticles for novel applications and tissue delivery, the spotlight remains on delivery as the key to achieving clinical and commercial success, unlocking new therapeutic horizons.

Immerse yourself in the only event dedicated entirely to lipid-based nanoparticle delivery, where we bring together 120+ experts in LNP non-clinical, delivery, particle engineering, and formulation. Together, we're on a mission to revolutionize drug delivery, conquering the intricate challenges of lipid-based nanoparticle delivery beyond RNAs and extending cargos to destinations beyond the liver.

Join us at the forefront of innovation as we focus on unlocking lipid-based nanoparticle efficacy through advanced delivery strategies. Across 3 days of carefully curated content, experience the cutting edge of innovation as we refine dosing strategies and minimize off-target effects to enhance therapeutic efficacy while reducing toxicity. Stay ahead of the curve with insights into device-formulation compatibility for cuttingedge routes of administration, tailoring delivery methods to your specific target of interest. Unlock the potential of LNPs to reach challenging tissues, customized to suit your unique therapeutic application.

URLs:
Tickets: https://go.evvnt.com/2315995-2?pid=1052
Brochure: https://go.evvnt.com/2315995-3?pid=1052

Prices:
Conference + Workshop Day - Pharma and Biotech Pricing : USD 4397.00,
Conference Only - Pharma and Biotech Pricing: USD 2999.00,
Conference + Workshop Day - Solution Provider Pricing : USD 5297.00,
Conference Only - Solution Provider Pricing : USD 3699.00,
Conference + Workshop Day - Academic and Research Pricing : USD 3797.00,
Conference Only - Academic and Research Pricing: USD 2599.00

Amey Bandekar, Associate Director, Sanofi, Ching Kim, Tye Director, Head, Nanoparticle, Sanofi, Daniel Tondera, Head, Biology, Pantherna Therapeutics, Daryl Drummond, Chief Scientific Officer, Akagera Medicines, Diane Nelson, Biomedical Engineer, National Institute of Standards and Technology, George Dakwar, Director, Formulation Platform, CureVac, Hema Choudhary, Postdoctoral Fellow, Innovative Genomics Institute University of California, Berkeley, James Leamon, Medical Device and Combination Product Design and Development, Independent Expert, Formerly Jazz Pharmaceuticals, Jee-Young Park, Executive Director, Business Development, MediciBio, Jieni Xu, Principal Scientist, LNP Formulation, Kernal Biologics, Jivan Yewle, Director, Non-Viral Delivery, Mammoth Biosciences, Ketaki Deshmukh, Senior Formulation Scientist, Novo Nordisk, Mah Kheirabadi, Director, Discovery Chemistry, Entrada Therapeutics, Maria-Dolores Vazquez-Abad, Managing Director, Pfizer, Michael Monte, Senior Engineer, Tessera Therapeutics, Natalia Zisman, Director, CMC, Concardo, Priya Karmali, Chief Technology Officer, Capstan Therapeutics, Russell Johnson, Vice President, Drug Delivery and Formulation, Omega Therapeutics, Sam Lai Professor, UNC Eshelman, School of Pharmacy, University of North Carolina, Shashank Shukla, Principal Scientist, Novel Drug Delivery, SalioGen Therapeutics